Figure 5

Immunoregulation of FMT in the liver. (A) Pro-inflammation-associated gene expression in the liver. (B,C) Foxp3, IFN-γ, IL-4, IL-17 and IL-22 protein expression levels in the liver. (D–I) Immunohistochemistry for Foxp3, IFN-γ, IL-4, IL-17 and IL-22 in the liver showed that Foxp3, IL-4, and IL-22 were increased and IFN-γ and IL-17 were decreased after FMT intervention. The data represent the mean ± S.E.M. * P < 0.05, ** P < 0.01 and *** P < 0.001.